A combination of metabolomics and metallomics studies of urine and serum from hypercholesterolaemic rats after berberine injection

被引:29
作者
Liu, Feng [1 ]
Gan, Pei Pei [1 ]
Wu, Huanan [1 ]
Woo, Wei Shan [1 ]
Ong, Eng Shi [2 ]
Li, Sam Fong Yau [1 ]
机构
[1] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore
[2] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117597, Singapore
关键词
Metabolomics; Metallomics; Berberine; H-1; NMR; ICP-MS; METABONOMIC ANALYSIS; PATTERN-RECOGNITION; DIABETES-MELLITUS; DRUG TOXICITY; NMR; SPECTROMETRY; METABOLISM; COMPLEXES; CHEMISTRY; ELEMENTS;
D O I
10.1007/s00216-012-5923-9
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
Berberine, long used as a remedy in China and India for intestinal infections, has been discovered in recent years in western countries and is now being used to treat ailments ranging from urinary tract infections to diabetes and obesity. In order to study the effect of berberine more deeply, a combined metabolomic and metallomic approach was developed in this study using the hypercholesterolaemic rat model, which involved the use of proton nuclear magnetic resonance for the analysis of rat urine to achieve metabolic fingerprinting and inductively coupled plasma mass spectrometry for the analysis of rat blood serum to achieve metallomic fingerprinting. The results obtained indicated that major metabolic processes like Krebs cycle, cholesterol metabolism and osmoregulation in hypercholesterolaemic rats are perturbed upon berberine injection. In addition, the changes of some elements, such as V, Mn, Na and K, revealed in the metallomic study may contribute to the search of new biomarkers for hypercholesterolaemic disease. We concluded that both the metabolomic and metallomic profiles of berberine-treated hypercholesterolaemic rats were different from those of the control group and that the selected metabolites and elements could probably be applied as potential biomarkers for the understanding of the effect of berberine on biochemical process in the animal model. Such a multi-analytical approach will potentially provide an information-rich platform for the elucidation of effects of xenobiotics and drug efficacy studies.
引用
收藏
页码:847 / 856
页数:10
相关论文
共 32 条
[1]
Vanadium(V) complexes in enzyme systems: aqueous chemistry, inhibition and molecular modeling in inhibitor design [J].
Bhattacharyya, S ;
Tracey, AS .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2001, 85 (01) :9-13
[2]
Comparative metabonomics of differential hydrazine toxicity in the rat and mouse [J].
Bollard, ME ;
Keun, HC ;
Beckonert, O ;
Ebbels, TMD ;
Antti, H ;
Nicholls, AW ;
Shockcor, JP ;
Cantor, GH ;
Stevens, G ;
Lindon, JC ;
Holmes, E ;
Nicholson, JK .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 204 (02) :135-151
[3]
1H NMR-based metabonomics for the diagnosis of inborn errors of metabolism in urine [J].
Constantinou, MA ;
Papakonstantinou, E ;
Spraul, M ;
Sevastiadou, S ;
Costalos, C ;
Koupparis, MA ;
Shulpis, K ;
Tsantili-Kakoulidou, A ;
Mikros, E .
ANALYTICA CHIMICA ACTA, 2005, 542 (02) :169-177
[4]
Scaling and normalization effects in NMR spectroscopic metabonomic data sets [J].
Craig, A ;
Cloareo, O ;
Holmes, E ;
Nicholson, JK ;
Lindon, JC .
ANALYTICAL CHEMISTRY, 2006, 78 (07) :2262-2267
[5]
Metabolomics: Current analytical platforms and methodologies [J].
Dunn, WB ;
Ellis, DI .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2005, 24 (04) :285-294
[6]
Monitoring diet effects via biofluids and their implications for metabolomics studies [J].
Gu, Haiwei ;
Chen, Huanwen ;
Pan, Zhengzheng ;
Jackson, Ayanna U. ;
Talaty, Nari ;
Xi, Bowei ;
Kissinger, Candice ;
Duda, Chester ;
Mann, Doug ;
Raftery, Daniel ;
Cooks, R. Graham .
ANALYTICAL CHEMISTRY, 2007, 79 (01) :89-97
[7]
Metallomics as integrated biometal science [J].
Haraguchi, H .
JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY, 2004, 19 (01) :5-14
[8]
Metabonomic modeling of drug toxicity [J].
Keun, HC .
PHARMACOLOGY & THERAPEUTICS, 2006, 109 (1-2) :92-106
[9]
Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma [J].
Ko, BS ;
Choi, SB ;
Park, SK ;
Jang, JS ;
Kim, YE ;
Park, S .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (08) :1431-1437
[10]
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states [J].
Lee, Yun S. ;
Kim, Woo S. ;
Kim, Kang H. ;
Yoon, Myung J. ;
Cho, Hye J. ;
Shen, Yun ;
Ye, Ji-Ming ;
Lee, Chul H. ;
Oh, Won K. ;
Kim, Chul T. ;
Hohnen-Behrens, Cordula ;
Gosby, Alison ;
Kraegen, Edward W. ;
James, David E. ;
Kim, Jae B. .
DIABETES, 2006, 55 (08) :2256-2264